Physician

Kevin Raymond Stein, M.D.

According to 2025 Medicare claims, Kevin Stein, M.D. (NPI: 1730221037) practices dermatology in the Winston-Salem, NC market, with the plurality of this provider's patient population coming from Forsyth, NC. This provider's primary affiliated billing organization is SKIN SURGERY CENTER PA (NPI: 1649237082; TIN: 562205718) and primary practice location at 27103-1319.

Stein's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,078 traditional Medicare patients, billed 5,806 HCPCS/CPT codes, and received $223,666 in Medicare payments. The top billing code was 17110 (Destruction of skin growth, 1-14 growths). Part D data shows 1,222 prescription claims across 587 beneficiaries totaling $1,290,376 in drug costs, led by Humira(Cf) Pen (Adalimumab). Open Payments data shows 73 records totaling $264,669. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $90,750 to $1,290,376. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$124K$247K2015 Medicare payment: $157,534 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $170,363 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $177,156 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $197,697 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $218,714 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $234,695 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $247,458 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $218,763 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $236,857 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $223,666 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20159333,605$157,534
20169984,142$170,363
20179713,794$177,156
20189619,827$197,697
20199917,451$218,714
20209184,705$234,695
20219494,972$247,458
20229125,025$218,763
20231,0075,174$236,857
20241,0785,806$223,666

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$645K$1.3M2015 Drug cost: $90,750 (USD; Tot_Drug_Cst)2016 Drug cost: $283,146 (USD; Tot_Drug_Cst)2017 Drug cost: $315,095 (USD; Tot_Drug_Cst)2018 Drug cost: $338,797 (USD; Tot_Drug_Cst)2019 Drug cost: $384,864 (USD; Tot_Drug_Cst)2020 Drug cost: $549,999 (USD; Tot_Drug_Cst)2021 Drug cost: $705,639 (USD; Tot_Drug_Cst)2022 Drug cost: $656,185 (USD; Tot_Drug_Cst)2023 Drug cost: $734,005 (USD; Tot_Drug_Cst)2024 Drug cost: $1,290,376 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015412719$90,750
2016465844$283,146
20177601,517$315,095
20186331,320$338,797
20196661,300$384,864
20206301,279$549,999
2021468996$705,639
2022437866$656,185
2023463944$734,005
20245871,222$1,290,376

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17110Destruction of skin growth, 1-14 growths238270$66
11102Biopsy of related skin growth, first growth361428$54
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more8221,084$54
17000Destruction of precancer skin growth, 1 growth489589$33
17003Destruction of precancer skin growth, 2-14 growths3751,752$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Humira(Cf) PenAdalimumab401,120$467,371
Dupixent PenDupilumab36994$134,065
OtezlaApremilast18540$87,290
Dupixent SyringeDupilumab14392$51,749
FluorouracilFluorouracil1002,907$7,744

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.53$840E.R. Squibb & Sons, L.L.C.
Research PaymentsReported research-related payment or transfer-of-value amount.20$263,830Takeda Pharmaceuticals U.S.A., Inc.
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Kevin Raymond Stein, M.D.?

Tedicare shows public-source Medicare data for Kevin Raymond Stein, M.D. (NPI 1730221037), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Kevin Raymond Stein, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Kevin Raymond Stein, M.D.?

Kevin Raymond Stein, M.D. is linked to SKIN SURGERY CENTER PA (billing NPI 1649237082) in the available physician profile data.

Does Kevin Raymond Stein, M.D. have Open Payments data?

Kevin Raymond Stein, M.D. has 73 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.